|Description||A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.|
|B0084-461855||2.5 g||$198||In stock|
|Brife Description||DPP-4 inhibitor, type 2 diabetes|
|Synonyms||Tradjenta; BI-1356; Ondero; Trajenta|
|Application||the treatment of type 2 diabetes|
Diprotin A has been found to be a novel dipeptidyl peptidase IV inhibitor and could be probably used as an anticancer agent.
ASP-8497 free base
ASP-8497 free base is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of ...
Sitagliptin phosphate monohydrate
Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts. It is used either alone or in combination with other oral anti...
ASP-4000 is a dipeptidyl peptidase 4 (DPP) inhibitor. It has antihyperglycemic activity.
Melogliptin is a selective dipeptidyl peptidase IV (DPP-IV) inhibitor. But No development was reported about Phase-II for Type-2 diabetes mellitus.
K 579, a cyanopyrrolidine compound, is a potent and slow-binding dipeptidyl peptidase IV (DPP IV) inhibitor. It has been shown to reduce blood DPP IV activity a...
ASP8497 is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of the GLP-1 l...
Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human...
DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including ...
Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. ASide from there use i...
Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.
Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.
Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as the treatment for type 2 diabetes.
DPPI 1c hydrochloride
The hydrochloride salt form of DPPI 1c, which has been found to be an inhibitor of DPP-IV and could improve glucose tolerance in diabetic mice.
Sitagliptin phosphate is a potent inhibitor of DPP4 in Caco-2 cell extracts.
NVP DPP 728 dihydrochloride
NVP DPP 728, a cyanopyrrolidine, is a potent, orally active dipeptidyl peptidase (DPP)-IV inhibitor with excellent oral bioavailability and potent antihyperglyc...
PK 44 phosphate
PK 44 phosphate is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV) with an IC50 value of 15.8 nM, which displays >1000-fold selectivity for DPP-IV over D...
Dutogliptin is a selective and orally active DPP4 inhibitor. It can improve glycaemic control in patients with type 2 diabetes. But phase III clinical trials fo...
Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
This active molecular is a selective dipeptidyl peptidase 4 (DPP4) inhibitor under the development of Dong-A. Evogliptin improves insulin resistance and delays ...